The efficacy and safety of rifaximin for the irritable bowel syndrome: A systematic review and meta-analysis

Objectives: Irritable bowel syndrome (IBS) affects 10-15% of the population, and treatment options are limited. Rifaximin is a minimally absorbed antibiotic that has shown efficacy in IBS patients. The objective of our study was to perform a meta-analysis and systematic review of available randomize...

Full description

Saved in:
Bibliographic Details
Main Authors: Stacy B. Menees, Monthira Maneerattannaporn, Hyungjin Myra Kim, William D. Chey
Other Authors: A. Alfred Taubman Health Care Center
Format: Review
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/15078
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
Be the first to leave a comment!
You must be logged in first